Peter Libby
Impact in
- Immunology top 0.01%
- Atherosclerosis and Cardiovascular Diseases
- Cardiology and Cardiovascular Medicine top 0.01%
Papers in
- Immunology 339
- Atherosclerosis and Cardiovascular Diseases 245
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 41
-
- Cell Adhesion Molecules Research 87
- Co-authors
- Paul M. Ridker (61 shared papers)Göran K. Hansson (19 shared papers)Galina K. Sukhova (130 shared papers)Uwe Schönbeck (46 shared papers)Attilio Maseri (1 shared paper)Masanori Aikawa (65 shared papers)Ralph Weissleder (48 shared papers)Francois Mach (23 shared papers)
- Journals
- Circulation (112 papers)Arteriosclerosis Thrombosis and Vascular Biology (60 papers)European Heart Journal (59 papers)Journal of the American College of Cardiology (48 papers)Circulation Research (48 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Peter Libby
956 papers receiving 194.0k citations
Peter Libby's Hit Papers
Peers
Comparison fields: 5 of 214
- Immunology 52.8k
- Cardiology and Cardiovascular Medicine 37.2k
- Immunology and Allergy 8.7k
- Cancer Research 18.9k
- Surgery 41.5k
Countries citing papers authored by Peter Libby
This map shows the geographic impact of Peter Libby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Libby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Libby more than expected).
Fields of papers citing papers by Peter Libby
This network shows the impact of papers produced by Peter Libby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Libby. The network helps show where Peter Libby may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Libby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 981 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Hit paper breakdown → | 2017 | 7350 |
| 2 | Inflammation in atherosclerosis Hit paper breakdown → | 2002 | 6887 |
| 3 | Inflammation and Atherosclerosis Hit paper breakdown → | 2002 | 6396 |
| 4 | Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Hit paper breakdown → | 2008 | 5385 |
| 5 | Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein Hit paper breakdown → | 2009 | 3240 |
| 6 | Progress and challenges in translating the biology of atherosclerosis Hit paper breakdown → | 2011 | 3171 |
| 7 | Inflammation in Atherosclerosis Hit paper breakdown → | 2012 | 2857 |
| 8 | Atherosclerosis Hit paper breakdown → | 2019 | 2363 |
| 9 | From Vulnerable Plaque to Vulnerable Patient Hit paper breakdown → | 2003 | 2267 |
| 10 | Diabetes and Atherosclerosis Hit paper breakdown → | 2002 | 2207 |
| 11 | Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. Hit paper breakdown → | 1994 | 2144 |
| 12 | Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine Hit paper breakdown → | 2011 | 2090 |
| 13 | Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease Hit paper breakdown → | 2017 | 2022 |
| 14 | The changing landscape of atherosclerosis Hit paper breakdown → | 2021 | 1972 |
| 15 | From Vulnerable Plaque to Vulnerable Patient Hit paper breakdown → | 2003 | 1944 |
| 16 | The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions Hit paper breakdown → | 2007 | 1911 |
| 17 | Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites Hit paper breakdown → | 2009 | 1847 |
| 18 | The immune response in atherosclerosis: a double-edged sword Hit paper breakdown → | 2006 | 1847 |
| 19 | Inflammation in Atherosclerosis Hit paper breakdown → | 2009 | 1763 |
| 20 | Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis Hit paper breakdown → | 2006 | 1660 |
About Peter Libby
Peter Libby is a scholar working on Immunology, Immunology and Allergy, Surgery, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 981 papers that have together received 201.4k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (245 papers), Lipoproteins and Cardiovascular Health (135 papers), Adipokines, Inflammation, and Metabolic Diseases (105 papers), Cell Adhesion Molecules Research (87 papers), Protease and Inhibitor Mechanisms (86 papers), Coronary Interventions and Diagnostics (76 papers), Inflammasome and immune disorders (52 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (41 papers). The work is most often cited by research in Immunology (52.8k citations), Cardiology and Cardiovascular Medicine (37.2k citations), Immunology and Allergy (8.7k citations), Cancer Research (18.9k citations) and Surgery (41.5k citations). Peter Libby has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Paul M. Ridker, Göran K. Hansson, Galina K. Sukhova, Uwe Schönbeck, Attilio Maseri, Masanori Aikawa, Ralph Weissleder, Francois Mach, Robert J. Glynn and Jean G. MacFadyen. Their work appears in journals such as Circulation, Arteriosclerosis Thrombosis and Vascular Biology, European Heart Journal, Journal of the American College of Cardiology and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.